Clinical outcomes of septal myectomy in hypertrophic cardiomyopathy with refractory symptoms: A single institutional experience from India

被引:0
|
作者
Maramreddy, Revanth [1 ,4 ]
Bahl, Ajay [2 ]
Tingnam, Shyam Kumar Singh [3 ]
机构
[1] Kasturba Med Coll & Hosp, Dept Cardiothorac Surg, Manipal, India
[2] PGIMER, Dept Cardiol, Chandigarh, India
[3] PGIMER, Dept Cardiothorac Surg, Chandigarh, India
[4] 1001B, Udupi 576104, Karnataka, India
来源
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH | 2023年 / 24卷
关键词
Hypertrophic cardiomyopathy; Left ventricular outflow tract; Mitral regurgitation; Systolic anterior motion; MITRAL REGURGITATION; OBSTRUCTIVE CARDIOMYOPATHY; RELIEF;
D O I
10.1016/j.cegh.2023.101408
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Myectomy is the surgical procedure for the treatment of hypertrophic cardiomyopathy (HCM) with refractory symptoms There is limited data available regarding the role of myectomy in HCM among the Indian population. This study is intended to assess the outcomes of myectomy in HCM.Methods: Change in the gradient across the left ventricular outflow tract and severity of mitral regurgitation after myectomy were studied using echocardiography. Functional status, exercise tolerance, and cardiac rhythm of the patients were studied before and after myectomy.Results: The study consists of eleven patients with HCM. Four patients were in NYHA grade II, seven were in NYHA grade III before surgery. After surgery nine were in NYHA grade I and two were in NYHA grade II. Exercise tolerance of the study group was in the range of 1 min before surgery and it improved to 6.27 min after surgery. LVOT gradient before surgery was 108.81 and 112.45 mm of Hg on TTE and TEE respectively and it was 17.9 and 15.63 mm of Hg on TEE and TTE respectively after myectomy. On TTE eight patients had severe MR and three had moderate MR before surgery, while nine of them had severe MR and two had moderate MR on TEE. In the immediate post-operative period nine had mild MR, one had moderate MR, whereas the remaining one patient underwent MVR. TTE at six months revealed mild MR in seven, moderate MR in two patients and one had no MR.Conclusions: Surgical septal myectomy is an effective treatment modality for obstructive HCM.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Comparable outcomes in single versus multiple septal branches alcohol ablation for obstructive hypertrophic cardiomyopathy☆
    Veselka, Josef
    Hansvenclova, Eva
    Tesarkova, Klara Hulikova
    Januska, Jaroslav
    Ibrahim, Karim
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 429
  • [42] Surgical Outcomes of Septal Myectomy With and Without Mitral Valve Surgeries in Hypertrophic Cardiomyopathy: a National Propensity-Matched Analysis (2005 to 2020)
    Faisaluddin, Mohammed
    Ahmed, Asmaa
    Patel, Harsh
    Thakkar, Samarthkumar
    Patel, Bhavin
    Balasubramanian, Senthil
    Feitell, Scott C.
    Shekar, Prem
    Rowin, Ethan
    Maron, Martin
    Ganatra, Sarju
    Dani, Sourbha S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 205 : 276 - 282
  • [43] Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy
    Altibi, Ahmed M.
    Ghanem, Fares
    Zhao, Yuanzi
    Elman, Miriam
    Cigarroa, Joaquin
    Nazer, Babak
    Song, Howard K.
    Masri, Ahmad
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
  • [44] Transaortic Shallow Septal Myectomy and Cutting of Secondary Fibrotic Mitral Valve Chordae-A 5-Year Single-Center Experience in the Treatment of Hypertrophic Obstructive Cardiomyopathy
    Dorobantu, Lucian Florin
    Iosifescu, Toma Andrei
    Ticulescu, Razvan
    Greavu, Maria
    Alexandrescu, Maria
    Dermengiu, Andrei
    Micheu, Miruna Mihaela
    Trofin, Monica
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [45] Clinical characteristics of hypertrophic cardiomyopathy in children: An 8-year single center experience
    Tunca Sahin, Gulhan
    Ozgur, Senem
    Kafali, Hasan Candas
    Sevinc Sengul, Fatma
    Haydin, Sertac
    Guzeltas, Alper
    Ergul, Yakup
    PEDIATRICS INTERNATIONAL, 2021, 63 (01) : 37 - 45
  • [46] Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes
    Kimmelstiel, Carey
    Zisa, David C.
    Kuttab, Johny S.
    Wells, Sophie
    Udelson, James E.
    Wessler, Benjamin S.
    Rastegar, Hassan
    Kapur, Navin K.
    Weintraub, Andrew R.
    Maron, Barry J.
    Maron, Martin S.
    Rowin, Ethan J.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (07)
  • [47] Mid-term outcomes of simultaneous coronary artery bypass graft surgery and septal myectomy in patients with hypertrophic obstructive cardiomyopathy: A case-controlled study
    Wang, Shengwei
    Cui, Hao
    Tang, Bing
    Zhu, Changsheng
    Meng, Liukun
    Yu, Qinjun
    Huang, Xiaohong
    Wu, Rong
    Wang, Shuiyun
    JOURNAL OF CARDIAC SURGERY, 2019, 34 (03) : 103 - 109
  • [48] Natural history and clinical outcomes of patients with hypertrophic cardiomyopathy from thin filament mutations
    Saul, Tatiana
    Bui, Quan M.
    Argiro, Alessia
    Keyt, Lucas
    Olivotto, Iacopo
    Adler, Eric
    ESC HEART FAILURE, 2024, : 3501 - 3510
  • [49] Institutional Experience With Transcatheter Mitral Valve Repair and Clinical Outcomes Insights From the TVT Registry
    Chhatriwalla, Adnan K.
    Vemulapalli, Sreekanth
    Holmes, David R., Jr.
    Dai, Dadi
    Li, Zhuokai
    Ailawadi, Gorav
    Glower, Donald
    Kar, Saibal
    Mack, Michael J.
    Rymer, Jennifer
    Kosinski, Andrzej S.
    Sorajja, Paul
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (14) : 1342 - 1352
  • [50] Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: Report from the registry data in Japan
    Goto, Daisuke
    Kinugawa, Shintaro
    Hamaguchi, Sanae
    Sakakibara, Mamoru
    Tsuchihashi-Makaya, Miyuki
    Yokota, Takashi
    Yamada, Satoshi
    Yokoshiki, Hisashi
    Tsutsui, Hiroyuki
    JOURNAL OF CARDIOLOGY, 2013, 61 (1-2) : 65 - 70